Serum autoantibodies in patients with primary sclerosing cholangitis.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Hepatology

• Publication date

  2000-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0168-8278(00)80061-6PMID 10707856
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Primary sclerosing cholangitis.

  2013cited by this paper
• Primary sclerosing cholangitis.

  2008cited by this paper
• Elevated Circulating Immune Complexes in Primary Sclerosing Cholangitis

  2007cited by this paper
• The Mayo risk score increases rapidly in the terminal phase of primary sclerosing cholangitis

  1998cited by this paper
• Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins

  1998cited by this paper
• Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificities may be associated with distinct clinical features.

  1998cited by this paper
• Peribiliary vascular plexus in primary sclerosing cholangitis and primary biliary cirrhosis.

  1997cited by this paper
• Ursodeoxycholic Acid

  1996cited by this paper
• Features of autoimmune hepatitis in primary sclerosing cholangitis: An evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis

  1996cited by this paper
• Anti‐neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders

  1996cited by this paper
• Precise quantitation of antinuclear antibodies on HEp-2 cells without the need for serial dilution

  1996cited by this paper
• Antineutrophil Cytoplasmic Autoantibodies with Specificity for Proteinase 3

  1996cited by this paper
• Case report: anti-proteinase 3 antibody activity in a patient with primary sclerosing cholangitis: clinical remission following ursodeoxycholic acid therapy.

  1996cited by this paper
• Bactericidal/permeability‐increasing protein (BPI) is an important antigen for anti‐neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis

  1995cited by this paper
• A novel class of autoantigens of anti-neutrophil cytoplasmic antibodies in necrotizing and crescentic glomerulonephritis: the lysosomal membrane glycoprotein h-lamp-2 in neutrophil granulocytes and a related membrane protein in glomerular endothelial cells

  1995cited by this paper
• Autoantibody profile of primary sclerosing cholangitis.

  1995cited by this paper
• Intrahepatic peribiliary vascular plexus in various hepatobiliary diseases: a histological survey.

  1994cited by this paper
• Anti‐neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: characterization and clinical correlates

  1994cited by this paper
• Hepatobiliary disease in ulcerative colitis. An analysis of 18 patients with hepatobiliary lesions classified as small-duct primary sclerosing cholangitis.

  1994cited by this paper
• Characterization of human autoantibodies reactive to gastric parietal cells.

  1993cited by this paper
• Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique.

  1992cited by this paper
• Degradation of endogenous bacterial cell wall polymers by the muralytic enzyme mutanolysin prevents hepatobiliary injury in genetically susceptible rats with experimental intestinal bacterial overgrowth.

  1992cited by this paper
• Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus.

  1992cited by this paper
• Association of anti-β2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus☆

  1992cited by this paper
• Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis.

  1991cited by this paper
• Antineutrophil cytoplasmic autoantibodies: Immunobiological aspects

  1991cited by this paper
• Association of infection due to Helicobacter pylori with specific upper gastrointestinal pathology.

  1991cited by this paper
• Significance and specificity of antibodies to neutrophils detected by western blotting for the serological diagnosis of primary sclerosing cholangitis

  1991cited by this paper
• Biliary tract disease in rats with experimental small bowel bacterial overgrowth

  1991cited by this paper
• Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro.

  1990cited by this paper
• Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).

  1990cited by this paper
• Activation of the complement system in primary sclerosing cholangitis.

  1989cited by this paper
• Which antigen to use in the detection of rheumatoid factors? Comparison of patients with rheumatoid arthritis and subjects with 'false positive' rheumatoid factor reactions.

  1989cited by this paper
• Comparison of IgA-class reticulin and endomysium antibodies in coeliac disease and dermatitis herpetiformis.

  1989cited by this paper
• Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus.

  1988cited by this paper
• Primary sclerosing cholangitis

  1988cited by this paper
• An autoantibody profile in primary sclerosing cholangitis.

  1987cited by this paper
• Primary sclerosing cholangitis in the presence of a lupus anticoagulant.

  1986cited by this paper
• Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis.

  1985cited by this paper
• Abnormal clearance of immune complexes from the circulation of patients with primary sclerosing cholangitis.

  1985cited by this paper
• Hepatobiliary disease in ulcerative colitis.

  1982cited by this paper
• Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology.

  1980cited by this paper

• Causal associations between primary sclerosing cholangitis and systemic lupus erythematosus: Evidence from Mendelian randomization and transcriptomic analyses

  2025cites this paper
• Clinical management of autoimmune liver diseases: juncture, opportunities, and challenges ahead

  2025cites this paper
• Systemic PCSK9 elevation characterises autoimmune liver disease across sexes

  2025influential citation
• British Society of Gastroenterology guidelines for diagnosis and management of autoimmune hepatitis

  2025cites this paper
• Diagnostic Tests in Primary Sclerosing Cholangitis: Serology, Elastography, Imaging, and Histology.

  2023cites this paper
• Immune-mediated cholangiopathies in children: the need to better understand the pathophysiology for finding the future possible treatment targets

  2023cites this paper
• The role of serology, liver function tests and imaging in screening of primary sclerosing cholangitis: the HelPSCreen score

  2023cites this paper
• Gastrointestinal and Hepatic Involvement in Primary Sjögren’s Syndrome: Case Report and Literature Review

  2023cites this paper
• A Review on Biomarkers for the Evaluation of Autoimmune Cholestatic Liver Diseases and Their Overlap Syndromes

  2022cites this paper
• Minimal-change nephropathy in systemic lupus erythematosus

  2022cites this paper
• Seronegative autoimmune diseases: A challenging diagnosis.

  2022cites this paper
• Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Review

  2022cites this paper
• A Systematic Review and Meta-Analysis on Metabolic Bone Disease in Patients with Primary Sclerosing Cholangitis

  2022cites this paper
• Immunoglobulin G4-related disease in gastroenterology.

  2021cites this paper
• Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis

  2021cites this paper
• Environmental exposure as a risk-modifying factor in liver diseases: Knowns and unknowns

  2021cites this paper
• Adaptive Immunity and the Clinical Definition of Autoantibodies

  2020cites this paper
• Primary Sclerosing Cholangitis

  2020cites this paper
• Anti‐glycoprotein 2 (anti‐GP2) IgA and anti‐neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3‐ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitis

  2020cites this paper
• 원발성 경화성 담관염과 원발성 담즙성 담관염의 최신 지견

  2020cites this paper
• The search for the Holy Grail: autoantigenic targets in primary sclerosing cholangitis associated with disease phenotype and neoplasia

  2020cites this paper
• Consensus guidelines: best practices for detection, assessment and management of suspected acute drug‐induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease

  2019cites this paper
• Cholestatic Liver Diseases

  2019cites this paper
• Primary Sclerosing Cholangitis: A Clinical Update

  2019cites this paper
• Association between serum IgG level and clinical course in primary sclerosing cholangitis

  2019cites this paper
• British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis

  2019cites this paper
• Important problems in the diagnosis and treatment of primary sclerosing cholangitis (based on the Russian consensus on diagnosis and treatment autoimmune hepatitis. Moscow, 2018).

  2019cites this paper
• Autoimmunassoziierte Gallenwegserkrankungen

  2019cites this paper
• Primary Sclerosing Cholangitis: A Concise Review of Diagnosis and Management

  2019cites this paper
• Catastrophic antiphospholipid syndrome (CAPS)-induced ischemic pancreatic ducts injury mimicking intraductal papillary mucinous neoplasm (IPMN).

  2018cites this paper
• 9 – Bile Duct Diseases

  2018cites this paper
• Učestalost ekstraintestinalnih manifestacija kronične upalne bolesti crijeva u djece

  2017cites this paper
• Primary sclerosing cholangitis: diagnostic and management challenges

  2017cites this paper
• Therapies for Primary Sclerosing Cholangitis: Vancomycin as a Novel Treatment Option

  2017cites this paper
• Pathogenesis and clinical spectrum of primary sclerosing cholangitis

  2017cites this paper
• Mujer anciana con insuficiencia hepática aguda

  2017cites this paper
• Primary sclerosing cholangitis: A review and update.

  2017cites this paper
• Elderly woman with acute liver failure.

  2017cites this paper
• Primary Sclerosing Cholangitis in an Elderly Patient: A Diagnostic Challenge

  2017cites this paper
• Overlap Syndromes of Primary Sclerosing Cholangitis

  2017cites this paper
• Digestive Involvement in the Antiphospholipid Syndrome

  2017cites this paper
• Small Duct Sclerosing Cholangitis: A Case Report and Review of Literature

  2017cites this paper
• Clinical usefulness of serum antibodies as biomarkers of gastrointestinal and liver diseases.

  2017cites this paper
• Human β-Defensin 2 in Primary Sclerosing Cholangitis

  2017cites this paper
• Cholestatische Lebererkrankungen

  2016cites this paper
• Primary Sclerosing Cholangitis

  2016cites this paper
• [Cholestatic liver disease].

  2016cites this paper
• Making Sense of Autoantibodies in Cholestatic Liver Diseases.

  2016cites this paper
• Inhibition of mast cell‐secreted histamine decreases biliary proliferation and fibrosis in primary sclerosing cholangitis Mdr2−/− mice

  2016cites this paper
• A case of primary sclerosing cholangitis with unique clinical features for a 5-year follow up

  2016cites this paper
• Genetic Risk and the Development of Autoimmune Liver Disease

  2015cites this paper
• Minimal-change nephropathy in systemic lupus erythematosus Nefrologia 2012

  2015cites this paper
• Assoziation laborchemischer und mikrobiologischer Befunde mit Krankheitsverlauf und Prognose der Primär Sklerosierenden Cholangitis - eine retrospektive Analyse

  2015cites this paper
• Clinical course of primary sclerosing cholangitis and concomitant ulcerative colitis - a preliminary report of retrospective study among patients from Southern Poland.

  2015cites this paper
• ACG Clinical Guideline: Primary Sclerosing Cholangitis

  2015cites this paper
• Biomarkers for disease progression of primary sclerosing cholangitis

  2015influential citation
• Comparative assessment of prognostic value for revised-Mayo risk model and Child-Pugh score in patients with primary sclerosing cholangitis.

  2015cites this paper
• Current Concepts in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis

  2015influential citation
• PR3-ANCA: A Promising Biomarker in Primary Sclerosing Cholangitis (PSC)

  2014cites this paper
• A Review of the Challenges Associated with the Diagnosis and Therapy of Primary Sclerosing Cholangitis

  2014cites this paper
• Diagnosis and classification of primary sclerosing cholangitis.

  2014cites this paper
• Hepatobiliary Manifestations of Inflammatory Bowel Disease

  2014cites this paper
• The Geoepidemiology of Autoimmune Liver Disease

  2014cites this paper
• The Spectrum of Hepatic Involvement in Pediatric Inflammatory Bowel Disease: An Analysis of the Development of Abnormal Liver Enzymes and Associated Clinical Variables

  2014cites this paper
• Autoimmune liver disease, autoimmunity and liver transplantation.

  2014cites this paper
• Primary Sclerosing Cholangitis (PSC)

  2014cites this paper
• Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.

  2013cites this paper
• Primary sclerosing cholangitis: an update

  2013cites this paper
• Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management.

  2013cites this paper
• Primary sclerosing cholangitis associated with severe ulcerative colitis in a young man

  2013cites this paper
• Primary Sclerosing Cholangitis – Diagnosis, Prognosis and Management

  2013cites this paper
• Primary sclerosing cholangitis.

  2013cites this paper
• Primer sklerozan kolanjit: Patogenez ve tedavi Primary sclerosing cholangitis:Pathogenesis and treatment

  2013cites this paper
• The spectrum of achalasia: lessons from studies of pathophysiology and high-resolution manometry.

  2013cites this paper
• Liver Disease in Pediatric Inflammatory Bowel Disease

  2013cites this paper
• Novel insights into autoimmune liver diseases provided by genome-wide association studies.

  2013cites this paper
• Regulatorische T-Zellen bei Erstdiagnose autoimmuner Lebererkrankungen - eine histologische und klinische Charakterisierung

  2012cites this paper
• Primary sclerosing cholangitis: etiopathogenesis and clinical management.

  2012cites this paper
• Primary Sclerosing Cholangitis and Ulcerative Colitis

  2012cites this paper
• PSC, AIH and overlap syndrome in inflammatory bowel disease.

  2012cites this paper
• Overlapping of Primary Biliary Cirrhosis and Small Duct Primary Sclerosing Cholangitis: First Case Report

  2012cites this paper
• [Primary sclerosing cholangitis: present views of its pathogenesis, diagnosis and treatment].

  2012cites this paper
• Approaches to the design of clinical trials for primary sclerosing cholangitis

  2012cites this paper
• Probable catastrophic antiphospholipid syndrome complicated with primary sclerosing cholangitis

  2012cites this paper
• 10 – Diseases of the bile ducts

  2012cites this paper
• Primary sclerosing cholangitis and interstitial nephropathy: an emerging association?

  2012cites this paper
• Analytical review of diagnosis and treatment strategies for dominant bile duct strictures in patients with primary sclerosing cholangitis.

  2011cites this paper
• 27 – Primary Sclerosing Cholangitis

  2011cites this paper
• Primary sclerosing cholangitis.

  2011cites this paper
• Immune-mediated diseases in primary sclerosing cholangitis.

  2011cites this paper
• Pathogenesis of primary sclerosing cholangitis

  2011cites this paper
• Coexistence of primary sclerosing cholangitis in a patient with myasthenia gravis

  2011influential citation
• Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue.

  2011cites this paper
• Sclerosing Cholangitis and Recurrent Pyogenic Cholangitis

  2010cites this paper
• Primary sclerosing cholangitis: overview and update

  2010cites this paper
• Laboratory diagnosis of autoimmune hepatitis

  2010influential citation
• Immune-mediated liver diseases: programmed cell death ligands and circulating apoptotic markers

  2009cites this paper
• Clinical features of antinuclear antibodies‐negative type 1 autoimmune hepatitis

  2009cites this paper
• Surveillance and Screening of Primary Sclerosing Cholangitis

  2009cites this paper
• Primary Sclerosing Cholangitis: A Clinical Case

  2009cites this paper